title: Office practice of osteoporosis evaluation.
abstract: Osteoporosis is a metabolic disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk. Bone fragility depends on bone density, turnover and microarchitectural features, such as relative trabecular volume, spacing, number and connectivity. Previous fragility fractures increase the fracture risk irrespective of bone density. Other risk factors must also be considered as many fractures occur in patients with osteopenia on densitometry. On the other hand, the diagnosis of osteoporosis and increased fracture risk should not be based on densitometric data alone when young populations such as men below 65 years, premenopausal women, adolescents and children are considered.
authors.affiliation: Division of Endocrinology, Federal University of Rio de Janeiro, RJ, Brazil. pglaca@yahoo.com
authors.forename: Paulo Gustavo S
authors.initials: PG
authors.lastname: Lacativa
authors.forename: Maria Lucia F
authors.initials: ML
authors.lastname: de Farias
mesh_terms: D000293:Adolescent; D000368:Aged; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D001842:Bone and Bones / Q000378:metabolism*; D002648:Child; D003720:Densitometry; D003937:Diagnosis, Differential; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D015415:Biomarkers